Heparin

pro-platelet basic protein ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29346400 The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation. 2018 1
2 28245630 Structural Basis of Native CXCL7 Monomer Binding to CXCR2 Receptor N-Domain and Glycosaminoglycan Heparin. 2017 Feb 26 1
3 29117741 β-Thromboglobulin may not reflect platelet activation during haemodialysis with the HeprAN membrane. 2017 Dec 1
4 20652010 CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells. 2010 1
5 18954601 Increased invasion through basement membrane by CXCL7-transfected breast cells. 2008 Nov 1
6 10956644 Stimulation of cellular sphingomyelin import by the chemokine connective tissue-activating peptide III. 2000 Dec 1 1
7 11085010 [Comparative studies of the adsorption behavior of plasma proteins to heparin-coated surfaces]. 2000 Oct 1
8 10494777 Platelet compatibility of an artificial surface modified with functionally active heparin. 1999 Sep 1
9 8695787 Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. 1996 Jul 15 2
10 8740352 Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. 1996 Mar 1
11 8817142 Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. 1996 1
12 8823102 Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. 1996 Oct 1
13 7852412 CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. 1995 Feb 17 2
14 1826095 Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. 1991 Jan 1
15 1832058 Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase. 1991 Sep 15 1
16 1833592 The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. 1991 Oct 1
17 1835913 Heparin-releasable platelet factor 4 in patients with coronary artery disease. 1991 Sep 4
18 2523801 Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. 1989 May 1 1
19 2847353 Immediate effects of heparin and LMW heparin on some platelet and endothelial derived factors. 1988 Jul 15 1
20 2437338 Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 May 1
21 2962279 [Prevention of thromboembolism during pregnancy in 3 sisters with congenital antithrombin III deficiency and decreased inducible fibrinolysis]. 1987 Nov 14 4
22 2931280 Effect of heparin and aspirin on platelet and clotting activation during leukapheresis. 1985 Aug 1
23 6202020 Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation. 1984 Feb 28 4
24 6221433 Hemodynamic and platelet response to the bolus intravenous administration of porcine heparin. 1983 Feb 28 1
25 6839017 Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins. 1983 Jun 1
26 6164044 [Changes in serum beta-thromboglobulin levels during oral contraception, cardiac valve disease and pulmonary embolism (author's transl)]. 1981 Apr 11 1
27 6158345 Conversion of low-affinity platelet factor 4 to beta-thromboglobulin by plasmin and trypsin. 1980 Oct 1 1